About Terumo
About Terumo
About Terumo Top

Dear Stakeholders

Terumo Group Identity

Terumo Group Code of Conduct

Corporate Profile

Corporate Governance

Compliance

Regulations and Standards

Directors and Executive Officers

History

Procurement Activity
Back
Business Overview
Business Overview
Business Overview Top

TIS Division（Terumo Interventional Systems）

Neurovascular Division (MicroVention)

Cardiovascular Division (Terumo Cardiovascular) / HeartSheet Division

Cardiovascular Division (Terumo Cardiovascular)

HeartSheet Division

Vascular Graft Division (Terumo Aortic)

Hospital Systems Division

Alliance Division

Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Back
Technology
Technology
Technology Top

Basic Information

Basic Information Top

Research and Development

Production and Supply

Intellectual Property

Terumo Fellows

Stories - Our Technologies
Back
Sustainability
Sustainability
Sustainability Top

News

Message from Top Management

Sustainability at the Terumo Group

Resolving Healthcare Challenges

Creating a Diverse and Inclusive Workplace

Reducing Environmental Footprint

Serving Our Communities

Report Library

Report Library Top

Back Numbers

GRI Standards Index
Back
Investors
Investors
Investors Top

Management Policy

Management Policy Top

Top Management Message

IR Policy

Business Risks

Financial Information

Financial Information Top

Quarterly Results

Financial Highlights

Segment Information

Shareholders & Stock

Shareholders & Stock Top

Stock Information

Shareholder Return

Chart

Credit Ratings and Corporate Bond

Analyst Coverage

Shareholders Meeting

Articles of Incorporation

IR Library

IR Library Top

Financial Statements

Presentations

Terumo Reports

Terumo Reports Top

Back Numbers

IR Events

Mail for IR Inquiry

Disclaimer
Back
Our Stories
Our Stories
Our Stories Top
Back
Newsroom
Newsroom
Newsroom Top

Newsroom2019

Newsroom2018

Newsroom2017

Newsroom2016

Newsroom2015

Newsroom2014
Back
Global Network
Global Network
Global Network Top

Japan

North America

South America

Europe, Middle East and Africa

Greater China

Asia and Pacific
Back

Newsroom 2021

February 24, 2021

Corporate

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.
Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care
February 8, 2021

General Hospital

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan
Aiming to Reduce the Burden on Patients Receiving Ambulatory Chemotherapy
February 4, 2021

Corporate

Terumo to Establish 'DX Promotion Department' for Accelerating Group-wide Digital Transformation
February 4, 2021

Corporate

Terumo Announces Change of Directors and Executive Officers
February 4, 2021

Financial

Terumo Revises its Full-Year Financial Guidance for FY2020
January 26, 2021

Cardiac and Vascular

Terumo Aortic Announces Publication of the Primary Endpoint Results from the TREO Pivotal Study
January 26, 2021

Cardiac and Vascular

Terumo Aortic Announces Completion of Enrolment of the RelayPro US Transection Pivotal Study
January 12, 2021

Cardiac and Vascular

Lower-Profile WEB Intrasaccular Aneurysm Treatment Device Receives FDA Approval
January 7, 2021

Blood Management

Terumo Blood and Cell Technologies Grants $50,000 to Support Blood Donor Education Program
ADRP is developing resources to elevate awareness of the need for blood donations
January 5, 2021

Corporate

Terumo Enters 100th Anniversary Year

T
O
P